Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, cilt.23, ss.196-200, 2017 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 23
- Basım Tarihi: 2017
- Doi Numarası: 10.1016/j.jiac.2016.12.003
- Dergi Adı: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.196-200
- Çukurova Üniversitesi Adresli: Hayır